Wentao Tian

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Systematic Review

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Therapeutic advances in medical oncology

Cancer medicine

OncoTargets and therapy

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Wentao Tian, Lishui Niu, Rongrong Zhou, Ziqi Wang, Jiaoyang Ning, Ruoyu Lu, Yin Shi, Zhaohua Tan
Cost-effectiveness analysis of osimertinib plus chemotherapy for patients with EGFR-mutated advanced non-small cell lung cancer. Cancer medicine 13 (16) (2024)
Wentao Tian, Lishui Niu, Yin Shi, Shuishi Li, Rongrong Zhou
First-line treatments for advanced non-squamous non-small cell lung cancer with immune checkpoint inhibitors plus chemotherapy: a systematic review, network meta-analysis, and cost-effectiveness analysis. Therapeutic advances in medical oncology 16 (2024)
Wentao Tian, Lishui Niu, Yin Shi, Shuishi Li, Rongrong Zhou
First-line treatments for advanced non-squamous non-small cell lung cancer with immune checkpoint inhibitors plus chemotherapy: a systematic review, network meta-analysis, and cost-effectiveness analysis. Therapeutic advances in medical oncology 16 (2024)
Wentao Tian, Lishui Niu, Rongrong Zhou, Ziqi Wang, Jiaoyang Ning, Ruoyu Lu, Yin Shi, Zhaohua Tan
Cost-effectiveness analysis of osimertinib plus chemotherapy for patients with EGFR-mutated advanced non-small cell lung cancer. Cancer medicine 13 (16) (2024)
Wentao Tian, Nuopei Tan, Jiawen Ke, Ji'an Zou, Xiaohan Liu, Yue Pan, Yue Zeng, Yurong Peng, Fang Wu
Adjuvant EGFR tyrosine kinase inhibitors for patients with resected EGFR -mutated non-small-cell lung cancer: a network meta-analysis. Future oncology (London, England) 18 (21) (2022)
Wentao Tian, Chenghui Cao, Long Shu, Fang Wu
Anti-Angiogenic Therapy in the Treatment of Non-Small Cell Lung Cancer. OncoTargets and therapy 13 (2020)